List of Tables
Table 1. COVID-19 Molecular Diagnostics Market Trends
Table 2. COVID-19 Molecular Diagnostics Market Drivers & Opportunity
Table 3. COVID-19 Molecular Diagnostics Market Challenges
Table 4. COVID-19 Molecular Diagnostics Market Restraints
Table 5. Global COVID-19 Molecular Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global COVID-19 Molecular Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies COVID-19 Molecular Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies COVID-19 Molecular Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of COVID-19 Molecular Diagnostics
Table 10. Global COVID-19 Molecular Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global COVID-19 Molecular Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global COVID-19 Molecular Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global COVID-19 Molecular Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global COVID-19 Molecular Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global COVID-19 Molecular Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global COVID-19 Molecular Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global COVID-19 Molecular Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global COVID-19 Molecular Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global COVID-19 Molecular Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global COVID-19 Molecular Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global COVID-19 Molecular Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Cellex Basic Information List
Table 32. Cellex Description and Business Overview
Table 33. Cellex COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Cellex (2019-2024)
Table 35. Cellex Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. BioMedomics Basic Information List
Table 47. BioMedomics Description and Business Overview
Table 48. BioMedomics COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BioMedomics (2019-2024)
Table 50. BioMedomics Recent Developments
Table 51. BD Basic Information List
Table 52. BD Description and Business Overview
Table 53. BD COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BD (2019-2024)
Table 55. BD Recent Developments
Table 56. Henry Schein Basic Information List
Table 57. Henry Schein Description and Business Overview
Table 58. Henry Schein COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Henry Schein (2019-2024)
Table 60. Henry Schein Recent Developments
Table 61. Safecare Bio-Tech Basic Information List
Table 62. Safecare Bio-Tech Description and Business Overview
Table 63. Safecare Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Safecare Bio-Tech (2019-2024)
Table 65. Safecare Bio-Tech Recent Developments
Table 66. Thermo Fisher Basic Information List
Table 67. Thermo Fisher Description and Business Overview
Table 68. Thermo Fisher COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Thermo Fisher (2019-2024)
Table 70. Thermo Fisher Recent Developments
Table 71. Bio-rad Basic Information List
Table 72. Bio-rad Description and Business Overview
Table 73. Bio-rad COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bio-rad (2019-2024)
Table 75. Bio-rad Recent Developments
Table 76. Agilent Basic Information List
Table 77. Agilent Description and Business Overview
Table 78. Agilent COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Agilent (2019-2024)
Table 80. Agilent Recent Developments
Table 81. Ortho Clinical Diagnostics Basic Information List
Table 82. Ortho Clinical Diagnostics Description and Business Overview
Table 83. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Ortho Clinical Diagnostics (2019-2024)
Table 85. Ortho Clinical Diagnostics Recent Developments
Table 86. Zhejiang Orient Gene Biotech Basic Information List
Table 87. Zhejiang Orient Gene Biotech Description and Business Overview
Table 88. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Zhejiang Orient Gene Biotech (2019-2024)
Table 90. Zhejiang Orient Gene Biotech Recent Developments
Table 91. Innovita Biological Technology Basic Information List
Table 92. Innovita Biological Technology Description and Business Overview
Table 93. Innovita Biological Technology COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Innovita Biological Technology (2019-2024)
Table 95. Innovita Biological Technology Recent Developments
Table 96. Guangzhou Wondfo Biotech Basic Information List
Table 97. Guangzhou Wondfo Biotech Description and Business Overview
Table 98. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 99. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangzhou Wondfo Biotech (2019-2024)
Table 100. Guangzhou Wondfo Biotech Recent Developments
Table 101. Guangdong Hecin-Scientific Basic Information List
Table 102. Guangdong Hecin-Scientific Description and Business Overview
Table 103. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 104. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangdong Hecin-Scientific (2019-2024)
Table 105. Guangdong Hecin-Scientific Recent Developments
Table 106. Dynamiker Biotechnology (Tianjin) Basic Information List
Table 107. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 108. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 109. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Dynamiker Biotechnology (Tianjin) (2019-2024)
Table 110. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 111. ADVAITE Basic Information List
Table 112. ADVAITE Description and Business Overview
Table 113. ADVAITE COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 114. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of ADVAITE (2019-2024)
Table 115. ADVAITE Recent Developments
Table 116. Mayo Clinic Laboratories Basic Information List
Table 117. Mayo Clinic Laboratories Description and Business Overview
Table 118. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 119. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mayo Clinic Laboratories (2019-2024)
Table 120. Mayo Clinic Laboratories Recent Developments
Table 121. Chembio Diagnostics Basic Information List
Table 122. Chembio Diagnostics Description and Business Overview
Table 123. Chembio Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 124. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Chembio Diagnostics (2019-2024)
Table 125. Chembio Diagnostics Recent Developments
Table 126. Mount Sinai Laboratory Basic Information List
Table 127. Mount Sinai Laboratory Description and Business Overview
Table 128. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 129. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mount Sinai Laboratory (2019-2024)
Table 130. Mount Sinai Laboratory Recent Developments
Table 131. QIAGEN Basic Information List
Table 132. QIAGEN Description and Business Overview
Table 133. QIAGEN COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 134. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of QIAGEN (2019-2024)
Table 135. QIAGEN Recent Developments
Table 136. Bioer Basic Information List
Table 137. Bioer Description and Business Overview
Table 138. Bioer COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 139. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bioer (2019-2024)
Table 140. Bioer Recent Developments
Table 141. Biosynex Basic Information List
Table 142. Biosynex Description and Business Overview
Table 143. Biosynex COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 144. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Biosynex (2019-2024)
Table 145. Biosynex Recent Developments
Table 146. Esco Basic Information List
Table 147. Esco Description and Business Overview
Table 148. Esco COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 149. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Esco (2019-2024)
Table 150. Esco Recent Developments
Table 151. Analytik Jena Basic Information List
Table 152. Analytik Jena Description and Business Overview
Table 153. Analytik Jena COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 154. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Analytik Jena (2019-2024)
Table 155. Analytik Jena Recent Developments
Table 156. Techne Basic Information List
Table 157. Techne Description and Business Overview
Table 158. Techne COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 159. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Techne (2019-2024)
Table 160. Techne Recent Developments
Table 161. Da An Gene Basic Information List
Table 162. Da An Gene Description and Business Overview
Table 163. Da An Gene COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 164. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Da An Gene (2019-2024)
Table 165. Da An Gene Recent Developments
Table 166. BGI Basic Information List
Table 167. BGI Description and Business Overview
Table 168. BGI COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 169. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BGI (2019-2024)
Table 170. BGI Recent Developments
Table 171. Shanghai ZJ Bio-Tech Basic Information List
Table 172. Shanghai ZJ Bio-Tech Description and Business Overview
Table 173. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
Table 174. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Shanghai ZJ Bio-Tech (2019-2024)
Table 175. Shanghai ZJ Bio-Tech Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. COVID-19 Molecular Diagnostics Downstream Customers
Table 179. COVID-19 Molecular Diagnostics Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
Table 183. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. COVID-19 Molecular Diagnostics Product Picture
Figure 2. Global COVID-19 Molecular Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. COVID-19 Molecular Diagnostics Report Years Considered
Figure 5. Global COVID-19 Molecular Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 7. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. High-throughput Sequencing Picture
Figure 9. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Picture
Figure 10. Immunological Detection Picture
Figure 11. Global COVID-19 Molecular Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global COVID-19 Molecular Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Scientific Research
Figure 15. Product Picture of Biodiagnostics
Figure 16. Global COVID-19 Molecular Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global COVID-19 Molecular Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value (%), (2019-2030)
Figure 29. United States COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 35. China COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 37. China COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 47. India COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 49. India COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 50. COVID-19 Molecular Diagnostics Industrial Chain
Figure 51. COVID-19 Molecular Diagnostics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
